Search research articles
Contact Us
Filters
Showing results (71-80 of 123) with videos related to
Page
of 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2006
Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer
Anthony W Tolcher, Desiree Hao, Johann de Bono, et al.
Investigational New Drugs
|
December 3, 2017
Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer
Jonathan W Goldman, Lee S Rosen, Anthony W Tolcher, et al.
Cancer Chemotherapy and Pharmacology
|
December 4, 2013
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
Anthony W Tolcher, Wendi V Rodrigueza, Drew W Rasco, et al.
Cancer Chemotherapy and Pharmacology
|
February 10, 2011
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors
Alejandro D Ricart, Edward A Ashton, Matthew M Cooney, et al.
Cancer Chemotherapy and Pharmacology
|
February 7, 2013
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Shahneen K Sandhu, Kyri Papadopoulos, Peter C Fong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor
Desirée Hao, Lisa A Hammond, S Gail Eckhardt, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2009
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies
Chia-Chi Lin, Muralidhar Beeram, Eric K Rowinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer
Chris H Takimoto, Lisa A Hammond-Thelin, Jane E Latz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2017
Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors
Anthony W Tolcher, Mario Sznol, Siwen Hu-Lieskovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2004
ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas
Johann S de Bono, Anthony W Tolcher, Andre Forero, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 123) with videos related to
Sort By:
Page
of 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2006
Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer
Anthony W Tolcher, Desiree Hao, Johann de Bono, et al.
Investigational New Drugs
|
December 3, 2017
Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer
Jonathan W Goldman, Lee S Rosen, Anthony W Tolcher, et al.
Cancer Chemotherapy and Pharmacology
|
December 4, 2013
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
Anthony W Tolcher, Wendi V Rodrigueza, Drew W Rasco, et al.
Cancer Chemotherapy and Pharmacology
|
February 10, 2011
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors
Alejandro D Ricart, Edward A Ashton, Matthew M Cooney, et al.
Cancer Chemotherapy and Pharmacology
|
February 7, 2013
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Shahneen K Sandhu, Kyri Papadopoulos, Peter C Fong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor
Desirée Hao, Lisa A Hammond, S Gail Eckhardt, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2009
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies
Chia-Chi Lin, Muralidhar Beeram, Eric K Rowinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer
Chris H Takimoto, Lisa A Hammond-Thelin, Jane E Latz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2017
Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors
Anthony W Tolcher, Mario Sznol, Siwen Hu-Lieskovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2004
ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas
Johann S de Bono, Anthony W Tolcher, Andre Forero, et al.
Page
of 13